What should a patient tell the anesthesia team before surgery or sedation while using tirzepatide?

Patients must tell their anesthesia team they use tirzepatide. The drug delays stomach emptying, increasing the risk of aspiration during surgery or sedation.

Why Anesthesia Teams Need to Know About Tirzepatide Use

Tirzepatide, sold as Zepbound and Mounjaro, is a dual GIP and GLP-1 receptor agonist. One of its primary mechanisms is delaying gastric emptying, which means food stays in your stomach for longer. This effect helps promote satiety and manage blood sugar.

While beneficial for weight loss and diabetes, delayed gastric emptying poses a significant risk during sedation or general anesthesia. Anesthesia suppresses the body's natural reflexes, like coughing and gagging, that protect your airway.

If the stomach is not empty during a procedure, its contents can be regurgitated and inhaled into the lungs. This serious complication is known as pulmonary aspiration. Informing your anesthesia team about tirzepatide use is critical for them to mitigate this risk.

This safety protocol is a key part of any physician-supervised weight management program. To understand more about our comprehensive approach to patient care, explore our other GOAL.MD [answers](/answers).

The Risk of Pulmonary Aspiration During Anesthesia

Pulmonary aspiration occurs when stomach contents, such as food particles or acidic fluid, are inhaled into the windpipe and lungs. This can happen when a patient under anesthesia regurgitates.

The consequences of aspiration can be severe, ranging from chemical pneumonitis (inflammation caused by stomach acid) to bacterial pneumonia and Acute Respiratory Distress Syndrome (ARDS), a form of lung failure.

This is why patients are instructed to fast (not eat or drink) for a specific period before any procedure requiring anesthesia. Fasting is designed to ensure the stomach is empty, minimizing the risk of regurgitation and aspiration.

Becausetirzepatide slows digestion, standard fasting times may not be sufficient. A patient can follow fasting rules perfectly and still have significant residual contents in their stomach, making communication with the anesthesia team essential.

ASA Guidelines for Holding Tirzepatide Before Surgery

The American Society of Anesthesiologists (ASA) has released consensus-based guidance for managing patients on GLP-1 receptor agonists like tirzepatide before surgery.

For patients taking a weekly dose of a GLP-1 agonist, such as tirzepatide, the ASA suggests considering holding the medication for the week prior to the procedure or surgery.

For patients on a daily-dosed GLP-1 agonist, the guidance suggests holding the dose on the day of the procedure.

These are general recommendations. You must consult your prescribing physician and surgical team for specific instructions. They will provide a personalized plan based on your health, the reason for taking tirzepatide (diabetes vs. weight loss), and the nature of your procedure.

What to Expect on the Day of Your Procedure

Upon learning you take tirzepatide, your anesthesia team will likely ask more detailed questions about your last dose, symptoms of slowed digestion (like nausea, bloating, or vomiting), and your last food and drink intake.

In some cases, the anesthesiologist may perform a point-of-care gastric ultrasound. This is a quick, non-invasive scan on your abdomen to visually assess the contents of your stomach and determine if it is safe to proceed.

If a significant amount of food or liquid is found in the stomach, or if the risk of aspiration is otherwise deemed high, the anesthesia team may need to adjust the anesthetic plan. This might involve using a specific technique called rapid sequence intubation.

For patient safety, if the risk of aspiration is considered too great, your procedure may be postponed. While inconvenient, this decision is made solely to protect you from a potentially life-threatening complication.

Bottom Line

The most critical step is open communication. You must inform your surgeon and anesthesia team that you are taking tirzepatide (Mounjaro or Zepbound) as early as possible before your procedure.

Be prepared to provide the date of your last injection, your dosage, and any symptoms of gastrointestinal upset you may be experiencing. This information is vital for your safety.

Follow the specific preoperative instructions provided by your medical team exactly. Do not stop or alter your medication schedule without explicit guidance from the physician who prescribes your tirzepatide in consultation with your surgeon.

This content is for informational purposes only and does not constitute medical advice.

Generated from GOAL.MD's physician-reviewed source library. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.